Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
D000123:Acetyltransferases; D000217:Acyltransferases / Q000378:metabolism*; D000818:Animals; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005449:Fluorenes / Q000494:pharmacology*; D006157:Guanosine Monophosphate / Q000494:pharmacology; D006877:Hydroxamic Acids; D006881:Hydroxyacetylaminofluorene / Q000378:metabolism / Q000494:pharmacology*; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism; D009154:Mutation / Q000187:drug effects*; D009696:Nucleic Acids / Q000378:metabolism; D051381:Rats; D012486:Salmonella typhimurium / Q000187:drug effects*
D005449:Fluorenes; D006877:Hydroxamic Acids; D009696:Nucleic Acids; D006881:Hydroxyacetylaminofluorene; D006157:Guanosine Monophosphate; D000217:Acyltransferases; D000123:Acetyltransferases; C019736:N-hydroxyarylamine O-acetyltransferase